NCT04109014

Brief Summary

The study uses a repeated measures, single group pretest-posttest design methodology to examine the feasibility, acceptability, and preliminary effectiveness of the FASTLANE II intervention aimed at decreasing risky sex behaviors among active methamphetamine using women. The study's methodology consists of two phases: 1) The feasibility and evaluation of recruitment capability and intervention effectiveness, and 2) qualitative acceptability interviews.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
20

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started May 2021

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 26, 2019

Completed
4 days until next milestone

First Posted

Study publicly available on registry

September 30, 2019

Completed
1.6 years until next milestone

Study Start

First participant enrolled

May 3, 2021

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2021

Completed
Last Updated

May 9, 2022

Status Verified

May 1, 2022

Enrollment Period

7 months

First QC Date

September 26, 2019

Last Update Submit

May 5, 2022

Conditions

Keywords

Cognitive BehavioralQualitative InterviewsMotivational Interviewing

Outcome Measures

Primary Outcomes (4)

  • Depression

    Participants will be asked to complete the Beck Depression Inventory (BDI-II) scale. A total of 21 items assess depressive symptoms over the past 2 weeks (including today), and are summed to create a summary score (alpha = 0.91). We used established cutoffs for minimal (0-13), mild (14-19), moderate (20-28), and severe depressive symptoms (29-63).

    9-12 weeks

  • Sex Practices

    Assesses number of times participants engaged in sexual behavior, (vaginal, oral, and anal sex). Follow-up questions assess number of times these sexual acts were protected. Use of condoms or oral dams or nonpenetrative (e.g., manual sex) excluding oral sex. Using these data, three outcome variables will be used: (a) total protected sex acts, (b) total unprotected sex acts, and (c) percentage of safer sex behaviors (i.e., ratio) by dividing protected sex behaviors by the total number of sex behaviors over the past 2 months.

    9-12 weeks

  • Negotiating Self-Efficacy for Safer Sex

    Seven questions pertaining to self-efficacy for negotiation of safer sex, including perceived ability to bring up the topic of safer sex with any partner, negotiate condom use with any partner, and convince a partner to use a condom if he or she resisted. Participants presented with a statement about being able to negotiate safer sex (e.g., ''I can persuade partners to try different types of condoms'') and rate agreement ranging from 1 (strongly disagree) to 4 (strongly agree). Total sum score with higher scores greater self-efficacy.

    9-12 weeks

  • Methamphetamine Use

    Asked to report number of days and grams (or preferred unit) of methamphetamine used in the past 30 days. They will be asked how often they snort, smoked, injected, injected in combination with another drug, or used in any other way in the past 2 months. Response options 0 = never, 1 = once in a while, 2 = fairly often, and 3 = very often. The items will be summed to create a summary score of "frequency of meth use across different methods in the past 2 months." Amount responses will be converted to grams using a standard formula (e.g., 8 ball ¼ 3.5 g; ounce ¼ 28 g). Converted values will be multiplied by number of times used to calculate the number of grams of methamphetamine used in the past 30 days.

    9-12 weeks

Study Arms (1)

FASTLANE II Group

OTHER

Participants will participate in the FASTLANE II Intervention. Counseling sessions will focus on: 1) depressive symptoms, 2) methamphetamine use, and 3) sexual risk behaviors. Three sessions will be devoted to each topic area. Trained staff will use a client-centered approach and develop a goal for each area alongside the participant. Counseling sessions will remain confidential and will not be audio recorded.

Other: FASTLANE II

Interventions

The intervention will consist of nine weekly hour-long individual counseling sessions. The FL II sessions utilize a combination of Cognitive Behavioral Therapy (CBT) and Motivational Interviewing (MI) to reduce sexual risk behaviors and mental health symptoms. Thus, individuals develop a "toolbox" for mood self-management to improve emotional self-regulation and reduce maladaptive coping mechanisms to minimize drug and sex risk behavior. Participants will be considered as completing the FASTLANE Intervention upon completion of the nine weeks of sessions.

FASTLANE II Group

Eligibility Criteria

Age18 Years+
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Resident of San Antonio, Texas
  • Female
  • Mexican-American
  • HIV-negative
  • years of age or older
  • Self-identify as heterosexual
  • Have had unprotected sex with at least one opposite sex partner during the previous 2 months
  • Indicate that they have snorted or smoked methamphetamine at least once during the previous 2 months

You may not qualify if:

  • Not a resident of San Antonio, Texas
  • Male
  • Not Mexican-American
  • HIV-positive
  • Younger than 18 years of age
  • Do not self-identify as heterosexual
  • Have not had unprotected sex with at least one opposite sex partner during the previous 2 months
  • Indicate that they have not snorted or smoked methamphetamine at least once during the previous 2 months

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Proyecto SALTO Office

San Antonio, Texas, 78207, United States

Location

Related Publications (27)

  • Rigby SW, Johnson LF. The relationship between intimate partner violence and HIV: A model-based evaluation. Infect Dis Model. 2017 Feb 16;2(1):71-89. doi: 10.1016/j.idm.2017.02.002. eCollection 2017 Feb.

    PMID: 29928730BACKGROUND
  • Ulibarri MD, Strathdee SA, Patterson TL. Sexual and drug use behaviors associated with HIV and other sexually transmitted infections among female sex workers in the Mexico-US border region. Curr Opin Psychiatry. 2010 May;23(3):215-20. doi: 10.1097/YCO.0b013e32833864d5.

    PMID: 20308903BACKGROUND
  • Zlotnick C, Johnson DM, Kohn R. Intimate partner violence and long-term psychosocial functioning in a national sample of American women. J Interpers Violence. 2006 Feb;21(2):262-75. doi: 10.1177/0886260505282564.

    PMID: 16368765BACKGROUND
  • Bonomi AE, Anderson ML, Cannon EA, Slesnick N, Rodriguez MA. Intimate partner violence in Latina and non-Latina women. Am J Prev Med. 2009 Jan;36(1):43-48. doi: 10.1016/j.amepre.2008.09.027.

    PMID: 19095164BACKGROUND
  • Ulibarri MD, Hiller SP, Lozada R, Rangel MG, Stockman JK, Silverman JG, Ojeda VD. Prevalence and characteristics of abuse experiences and depression symptoms among injection drug-using female sex workers in Mexico. J Environ Public Health. 2013;2013:631479. doi: 10.1155/2013/631479. Epub 2013 May 12.

    PMID: 23737808BACKGROUND
  • Mausbach BT, Semple SJ, Strathdee SA, Zians J, Patterson TL. Efficacy of a behavioral intervention for increasing safer sex behaviors in HIV-positive MSM methamphetamine users: results from the EDGE study. Drug Alcohol Depend. 2007 Mar 16;87(2-3):249-57. doi: 10.1016/j.drugalcdep.2006.08.026. Epub 2006 Dec 19.

    PMID: 17182196BACKGROUND
  • Zule WA, Costenbader EC, Meyer WJ Jr, Wechsberg WM. Methamphetamine use and risky sexual behaviors during heterosexual encounters. Sex Transm Dis. 2007 Sep;34(9):689-94. doi: 10.1097/01.olq.0000260949.35304.22.

    PMID: 17471112BACKGROUND
  • McCoy HV, McCoy CB, Lai S. Effectiveness of HIV interventions among women drug users. Women Health. 1998;27(1-2):49-66. doi: 10.1300/J013v27n01_04.

    PMID: 9640634BACKGROUND
  • Ennis, S., M. Rios-Vargas, & N.G. Albert, The Hispanic Population 2010. 2011.

    BACKGROUND
  • Motel, S.E.P., Hispanics of Mexican Origin in the United States, 2010. 2012, Pew Research Center.

    BACKGROUND
  • Telles, E.E.V.O., Generations of Exclusion: Mexican Americans, Assimilation, and Race. 2008, Russell Sage Foundation.

    BACKGROUND
  • Caetano R, Field CA, Ramisetty-Mikler S, McGrath C. The 5-year course of intimate partner violence among White, Black, and Hispanic couples in the United States. J Interpers Violence. 2005 Sep;20(9):1039-57. doi: 10.1177/0886260505277783.

    PMID: 16051726BACKGROUND
  • Smith CA, Ireland TO, Park A, Elwyn L, Thornberry TP. Intergenerational continuities and discontinuities in intimate partner violence: a two-generational prospective study. J Interpers Violence. 2011 Dec;26(18):3720-52. doi: 10.1177/0886260511403751. Epub 2011 Aug 1.

    PMID: 21810795BACKGROUND
  • Jennings WG, Reingle JM, Staras SA, Maldonado-Molina MM. Substance Use as a Risk Factor for Intimate Partner Violence Overlap: Generational Differences Among Hispanic Young Adults. Int Crim Justice Rev. 2012 Jun 1;22(2):139-152. doi: 10.1177/1057567712442943.

    PMID: 25125930BACKGROUND
  • Nowotny KM, Frankeberger J, Rodriguez VE, Valdez A, Cepeda A. Behavioral, Psychological, Gender, and Health Service Correlates to Herpes Simplex Virus Type 2 Infection among Young Adult Mexican-American Women Living in a Disadvantaged Community. Behav Med. 2019 Jan-Mar;45(1):52-61. doi: 10.1080/08964289.2018.1447906. Epub 2018 May 9.

    PMID: 29558260BACKGROUND
  • United States Census Bureau, DP-1-Profile of General Population and Housing Characteristics: 2010. 2010.

    BACKGROUND
  • Economic Innovation Group, The 2016 Distressed Communities Index: An Analysis of Community Well- Being Across the United States. Economic Innovation Group.

    BACKGROUND
  • Quinn SC. Ethics in public health research: protecting human subjects: the role of community advisory boards. Am J Public Health. 2004 Jun;94(6):918-22. doi: 10.2105/ajph.94.6.918.

    PMID: 15249289BACKGROUND
  • Pitpitan, E.V., et al., Cognitive behavioral therapy for HIV-negative heterosexual meth users: the FASTLANE II intervention. Cognitive and Behavioral Practice, 2014. 21(2): p. 176-190.

    BACKGROUND
  • Pitpitan EV, Semple SJ, Zians J, Strathdee SA, Patterson TL. Mood, Meth, Condom Use, and Gender: Latent Growth Curve Modeling Results from a Randomized Trial. AIDS Behav. 2018 Sep;22(9):2815-2829. doi: 10.1007/s10461-018-2147-9.

    PMID: 29754267BACKGROUND
  • Beck, A., R. Steer, and G. Brown, Manual for the BDI-II. 1996, San Antonio, TX: Psychological Corporation.

    BACKGROUND
  • Corbin, J.M. and A. Strauss, Grounded theory research: Procedures, canons, and evaluative criteria. Qualitative sociology, 1990. 13(1): p. 3-21.

    BACKGROUND
  • Glaser, B. and A. Strauss, Discovery of grounded theory: Strategies for qualitative review. 1967, Chicago, IL: Aldine De Gruyter.

    BACKGROUND
  • LeCompte, M.D. and J.J. Schensul, Analyzing & interpreting ethnographic data. 1999: Rowman Altamira.

    BACKGROUND
  • Ragin, C.C., The Comparative Method: Moving Beyond Qualitative and Quantitative Strategies. 1987, Los Angeles: University of California Press.

    BACKGROUND
  • Ragin CC. Using qualitative comparative analysis to study causal complexity. Health Serv Res. 1999 Dec;34(5 Pt 2):1225-39. No abstract available.

    PMID: 10591281BACKGROUND
  • Spradley, J., The Ethnographic Interview. New York, NY: Holt, Rinehart and Winston. Inc, 1979.

    BACKGROUND

MeSH Terms

Conditions

Acquired Immunodeficiency SyndromeDepressionUnsafe Sex

Condition Hierarchy (Ancestors)

HIV InfectionsBlood-Borne InfectionsCommunicable DiseasesInfectionsSexually Transmitted Diseases, ViralSexually Transmitted DiseasesLentivirus InfectionsRetroviridae InfectionsRNA Virus InfectionsVirus DiseasesSlow Virus DiseasesGenital DiseasesUrogenital DiseasesImmunologic Deficiency SyndromesImmune System DiseasesBehavioral SymptomsBehaviorSexual Behavior

Study Officials

  • Alice Cepeda, PhD

    University of Southern California

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
PREVENTION
Intervention Model
SINGLE GROUP
Model Details: Quasiexperimental, single group pretest-posttest study design and qualitative interviews to evaluate feasibility, acceptability and effect.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

September 26, 2019

First Posted

September 30, 2019

Study Start

May 3, 2021

Primary Completion

December 1, 2021

Study Completion

December 1, 2021

Last Updated

May 9, 2022

Record last verified: 2022-05

Data Sharing

IPD Sharing
Will not share

Locations